crohn-s-disease

Documents about crohn-s-disease

• Cyclic Exclusive Enteral Nutrition as Maintenance Therapy for Pediatric Crohn's Disease#802040ClinicalTrials.gov
• Study Comparing Intravenous (IV)/Subcutaneous (SC) Risankizumab to IV/SC Ustekinumab to Assess Change in Crohn's Disease Activity Index (CDAI) in Adult Participants With Moderate to Severe Crohn's Disease (CD)#855782ClinicalTrials.gov
• Extracorporeal Photopheresis to Maintain Symptoms Remission During Steroid Withdrawal in Patients With Steroid-Dependent Crohn's Disease#885615ClinicalTrials.gov
• An Early Access Program For Ustekinumab In Participants With Moderately To Severely Active Crohn's Disease#160356ClinicalTrials.gov
• A Study of Vedolizumab in People With Ulcerative Colitis and Crohn's Disease#813710ClinicalTrials.gov
• Effectiveness of Rifaximin on Preventing Postoperative Recurrence in Crohn's Disease#838580ClinicalTrials.gov
• Target Engagement of EXL01 in the Prevention of Post-operative Recurrence of Crohn's Disease#900131ClinicalTrials.gov
• TRansmural hEaliNg Definition in CroHn's Disease (TRENCH 1)#902607ClinicalTrials.gov
• Efficacy of Cx601 (Darvadstrocel) for the Treatment of Perianal Fistulizing Crohn's Disease#918749ClinicalTrials.gov
• NIH Substudy of AIN457 (Anti-IL-17 Monoclonal Antibody) for Treatment of Moderate to Severe Crohn's Disease#1008031ClinicalTrials.gov
• Comparing Over the Counter Pain Medicines for Discomfort in Crohn's Disease (AVID-CD)#369953ClinicalTrials.gov
• Ustekinumab in Crohn’s Disease: New Data for Positioning in Treatment Algorithm#665325HAL (France)
• A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease#866116ClinicalTrials.gov
• Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease#874303ClinicalTrials.gov
• Unraveling the Blood Microbiome in Postoperative Recurrence of Crohn's Disease#908653ClinicalTrials.gov
• Immune Response Regulation and Nutritional Status of the Crohn's Disease Patients.#872626ClinicalTrials.gov
• Early Postoperative Recurrence in Crohn's Disease: Predictors of Research Targeting the Constitutional Mutation of IRGM#968516ClinicalTrials.gov
• A Study to Test the Effect of CDP870 in the Treatment of Crohn's Disease Over 26 Weeks, Comparing CDP870 to a Dummy Drug (Placebo)#854494ClinicalTrials.gov
• Darvadstrocel for Crohn's Fistula in the Realworld#916784ClinicalTrials.gov
• Assessment of Nutritional Knowledge in Patients With Inflammatory Bowel Disease#863887ClinicalTrials.gov
• A Humanized Anti-Interferon-γ Monoclonal Antibody (HuZAF) for Moderate to Severe Crohn's Disease#867560ClinicalTrials.gov
• Effect of VSL#3 on Intestinal Permeability in Pediatric Crohn's Disease#862297ClinicalTrials.gov
• PATHFINDER: Evaluating the Optimal First-Line Treatment Strategy for Moderate-to-Severely Active Ileal-dominant Crohn's Disease#407742ClinicalTrials.gov
• Upadacitinib in Isolated Small Bowel Versus Non-Small Bowel Crohn's Disease#862058ClinicalTrials.gov
• Safety of Mesentery-embedding Surgery in Patients With Ileocolic Crohn's Disease on Biotherapy#967421ClinicalTrials.gov
• Resistant Starch in Pediatric Inflammatory Bowel Disease (Crohn's Disease or Ulcerative Colitis)#873699ClinicalTrials.gov
• One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease#896674ClinicalTrials.gov
• Predictors Favoring the Role of Exclusive Enteral Nutrition in Active Crohn's Disease#826251ClinicalTrials.gov
• A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)#869954ClinicalTrials.gov
• Composite outcomes in observational studies of Crohn’s disease: a systematic review and meta-analysis#983961HAL (France)
• Therapeutic Optimization Study Based on MR Enterocolonography in Patients With Crohn's Disease#882119ClinicalTrials.gov
• Autologous Transplant Targeted Against Crohn's#969831ClinicalTrials.gov
• Endoscopic Stenting in Crohn Related Strictures#871771ClinicalTrials.gov
• Crohn's Disease#1042194University of Virginia Dataverse Dataverse OAI Archive
• The Role of Small Bowel Ultrasound in Initiation of Infliximab in Crohn's Disease Patients#993403ClinicalTrials.gov
• A Pharmacokinetic Study of Ustekinumab in Pediatric Subjects With Moderately to Severely Active Crohn's Disease#865254ClinicalTrials.gov
• A Study of Ustekinumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease#873399ClinicalTrials.gov
• A Study to Evaluate the Efficacy of Guselkumab in Chinese Participants With Crohn's Disease (CD)#896070ClinicalTrials.gov
• Cannabidiol Usage as an Adjunct Therapy for Crohn's Disease#899840ClinicalTrials.gov
• Post-marketing Registry Study of Infliximab for Injection in Chinese Pediatric Crohn's Disease Patients#901773ClinicalTrials.gov
• Induced Adult Refractory Active Crohn's Disease Clinical Relieving by Using Thalidomide#915042ClinicalTrials.gov
• Impact of Advanced Crohn's Disease Therapies on Sleep Quality#1009882ClinicalTrials.gov
• Study to Evaluate the Efficacy and Safety of Filgotinib in the Treatment of Small Bowel Crohn's Disease (SBCD)#803502ClinicalTrials.gov
• Acupuncture Reduces Relapse in Patients With Crohn's Disease: a Superiority Trial#825745ClinicalTrials.gov
• Safety and Efficacy of NNC 0142-0000-0002 in Subjects With Moderately to Severely Active Crohn's Disease#832572ClinicalTrials.gov
• Diagnostic Accuracy of Capsule Endoscopy in Small Bowel Crohn's Disease#851110ClinicalTrials.gov
• Follow-up to Welcome Study C87042 [NCT00308581] Examining Certolizumab Pegol (CDP870) in Subjects With Crohn's Disease#861407ClinicalTrials.gov
• A Study of Darvadstrocel for Treating Complex Perianal Fistulas in Children and Teenagers With Crohn's Disease#869291ClinicalTrials.gov
• A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease#891907ClinicalTrials.gov
• Comparison of the Therapeutic Effects of Balloon Assisted Enteroscopy Assisted Narrow Incision and Balloon Dilation in the Treatment of Crohn's Disease Small Intestinal Stenosis#849999ClinicalTrials.gov